XML 61 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 29, 2013
Sep. 30, 2012
Sep. 29, 2013
Sep. 30, 2012
Revenues $ 12,643 $ 12,953 $ 38,026 $ 40,766
Costs and expenses:        
Cost of sales(a) 2,287 [1] 2,309 [1] 6,792 [1] 7,068 [1]
Selling, informational and administrative expenses(a) 3,395 [1] 3,491 [1] 10,203 [1] 10,834 [1]
Research and development expenses(a) 1,627 [1] 1,887 [1] 4,867 [1] 5,461 [1]
Amortization of intangible assets 1,117 1,211 3,476 3,889
Restructuring charges and certain acquisition-related costs 233 312 547 1,085
Other (income)/deductions––net 411 937 (514) 3,264
Income from continuing operations before provision for taxes on income 3,573 [2] 2,806 [2] 12,655 [2] 9,165 [2]
Provision/(benefit) for taxes on income 985 (183) 3,876 1,622
Income from continuing operations 2,588 2,989 8,779 7,543
Discontinued operations:        
Income from discontinued operations––net of tax 36 225 326 734
Gain on disposal of discontinued operations––net of tax (25) 0 10,393 0
Discontinued operations––net of tax 11 225 10,719 734
Net income before allocation to noncontrolling interests 2,599 3,214 19,498 8,277
Less: Net income attributable to noncontrolling interests 9 6 63 22
Net income attributable to Pfizer Inc. $ 2,590 $ 3,208 $ 19,435 $ 8,255
Earnings per common share––basic(b):        
Income from continuing operations attributable to Pfizer Inc. common shareholders $ 0.39 [3] $ 0.40 [3] $ 1.26 [3] $ 1.00 [3]
Discontinued operations––net of tax $ 0.00 [3] $ 0.03 [3] $ 1.54 [3] $ 0.10 [3]
Net income attributable to Pfizer Inc. common shareholders $ 0.39 [3] $ 0.43 [3] $ 2.80 [3] $ 1.10 [3]
Earnings per common share––diluted(b):        
Income from continuing operations attributable to Pfizer Inc. common shareholders $ 0.39 [3] $ 0.40 [3] $ 1.25 [3] $ 1.00 [3]
Discontinued operations––net of tax $ 0.00 [3] $ 0.03 [3] $ 1.52 [3] $ 0.10 [3]
Net income attributable to Pfizer Inc. common shareholders $ 0.39 [3] $ 0.43 [3] $ 2.77 [3] $ 1.09 [3]
Weighted-average shares––basic 6,581 7,436 6,938 7,483
Weighted-average shares––diluted 6,656 7,508 7,016 7,550
Cash dividends paid per common share $ 0.24 $ 0.22 $ 0.72 $ 0.66
[1] Excludes amortization of intangible assets, except as disclosed in Note 9B. Goodwill and Other Intangible Assets: Other Intangible Assets.
[2] Income from continuing operations before provision for taxes on income.
[3] EPS amounts may not add due to rounding.